1. Home
  2. ZVIA vs MDWD Comparison

ZVIA vs MDWD Comparison

Compare ZVIA & MDWD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Zevia PBC

ZVIA

Zevia PBC

HOLD

Current Price

$2.61

Market Cap

193.4M

ML Signal

HOLD

Logo MediWound Ltd.

MDWD

MediWound Ltd.

N/A

Current Price

$18.77

Market Cap

230.7M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
ZVIA
MDWD
Founded
2007
2000
Country
United States
Israel
Employees
N/A
N/A
Industry
Beverages (Production/Distribution)
Medicinal Chemicals and Botanical Products
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
193.4M
230.7M
IPO Year
2021
2014

Fundamental Metrics

Financial Performance
Metric
ZVIA
MDWD
Price
$2.61
$18.77
Analyst Decision
Buy
Strong Buy
Analyst Count
5
2
Target Price
$4.89
$37.50
AVG Volume (30 Days)
816.1K
97.7K
Earning Date
11-05-2025
11-20-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$162,849,000.00
$20,932,000.00
Revenue This Year
$7.60
$15.89
Revenue Next Year
$6.70
$25.33
P/E Ratio
N/A
N/A
Revenue Growth
6.17
6.15
52 Week Low
$1.88
$14.14
52 Week High
$4.99
$22.51

Technical Indicators

Market Signals
Indicator
ZVIA
MDWD
Relative Strength Index (RSI) 53.69 58.14
Support Level $2.54 $18.55
Resistance Level $2.68 $19.40
Average True Range (ATR) 0.10 0.61
MACD -0.01 0.09
Stochastic Oscillator 63.69 77.08

Price Performance

Historical Comparison
ZVIA
MDWD

About ZVIA Zevia PBC

Zevia PBC is a beverage company disrupting the liquid refreshment beverage industry through refreshing, zero-calorie, zero-sugar, naturally sweetened beverages that are all Non-GMO Project Verified. It offers a platform of products that include a variety of flavors across Soda, Energy Drinks, Organic Tea, Mixers, Kidz drinks, and Sparkling Water. Its products are distributed across the U.S. and Canada through a network of retailers in the food, drug, mass, natural, and e-commerce channels. The company derives a majority of its revenue from the United States.

About MDWD MediWound Ltd.

MediWound Ltd is an integrated biopharmaceutical company focused on developing, manufacturing, and commercializing novel therapeutic products to address unmet medical needs in the fields of severe burns, chronic and other hard-to-heal wounds, connective tissue disorders, and other indications. Its first biopharmaceutical product, NexoBrid is an FDA-approved orphan biologic for eschar removal in severe burns that can replace surgical interventions and minimize associated costs and complications. Its other product candidates in different stages of the pipeline include EscharEx for debridement of chronic wounds, and MW005 for the treatment of non-melanoma skin cancer. The company derives a majority of its revenue from the United States and the rest from the EU and other international markets.

Share on Social Networks: